No Data
No Data
Emerging markets outlook: Interested in confirming the increase in trading volume in growth markets.
Interest in main stocks did not increase, and trading volume stunk this week in emerging markets. During the same period, while the Nikkei Average fell by -3.00%, the Growth Market Index fell by -3.69% and the Growth Market 250 Index fell by -4.22%. Similar to the Prime Market, there was a rollback of 'high market trading' at the beginning of the week, leading to a decline. Subsequently, influenced by the words and actions of the newly appointed Prime Minister Ishiba, buying in main stocks was held back, and short-term funds flowed into recent IPO stocks, among other reasons.
【New 5% Rule】: Comprising companies such as Uluru and Canvas.
<241A> Roxx Persol Career Co., Ltd. Representative Director Seo Yutaka Shareholding Percentage - 6.05% Reporting Obligation Date 2024/09/25 Roxx Co., Ltd. Nakajima Taro Shareholding Percentage - 16.63% Reporting Obligation Date 2024/09/25 <246A> Asua Kanjida Co., Ltd. Shareholding Percentage - 58.61% Reporting Obligation Date 2024/09/26 <3979> Stocks
Stocks that moved the previous day part1: Kaiom, Jayck, Grandies, etc.
Stocks that moved the previous day part1: Kayoum, Jekk, Grandees, and other stocks <Code> 25th closing price ⇒ Previous day comparison J Front <3086> 1534.5 +18.25 Revised upwards the performance and dividend estimates for the fiscal year ending February 2025. After opening high, it lost momentum. GENDA <9166> 2373 -134 Profit-taking sales dominant despite confirmation of Leo's 5.17% shareholding. Kayoum <4583> 114 +2 Business partnership with Merck & Co. in antibody production outsourcing services, etc. Jekk <7073> 2310
Active and newly established stocks in the afternoon session.
*J Front <3086> 1534.5 +1825 year 2020 February financial performance and dividends forecast revised upward. After the morning high, it lost momentum. *GENDA <9166> 2373 -134 Leo's 5.17% shareholding, but profit-taking sales are dominant. *KAIOMU <4583> 114 +2 Business partnership with Merck & Co. for antibody production outsourcing services. *JAKK <7073> 2310 +175 National qualification career consultant on the interview platform exceeds 3000 registrations. *GRANDI
Volume change rate ranking (13:00) ~ Kaiohm, Kyowa Kirin, etc. are ranked.
In the volume change rate ranking, you can understand the interest of market participants such as trends in buying and selling by comparing the average volume of the last 5 days with the volume on the delivery day. Top volume change rate [As of 13:32 on September 25] (Comparison of average volume for the last 5 days): Code => Stock => Volume => 5-day average volume => Volume change ratio => Stock price change rate <3696> Sirius 1046500 118780 235.07% -0.0942% <4583> Kai
Kaiome ranks in, forming a business alliance with merck & co in antibody production outsourcing services.
Kaiohm <4583> ranks in (as of 1:32 p.m.). Significantly up for the 4th consecutive day. During the lunch break period, it was announced that the Japanese subsidiary of the German science & technology company Merck has signed a business partnership agreement related to antibody production outsourcing services, becoming a buying catalyst. By combining Kaiohm's advanced technology with Merck's sales network, they will expand the sale of antibody production outsourcing services and antibody affinity maturation outsourcing services in Japan. Volume change rate top performers. [September 25th 13:32
No Data
No Data